Fabrinet filings document the company’s operating results, financial condition, governance matters and shareholder actions as a Cayman Islands registrant listed under the FN symbol. Its Form 8-K reports furnish quarterly and annual financial results press releases and also record material governance events, including board appointments, director retirements and executive incentive compensation arrangements.
Proxy materials and annual meeting reports disclose board elections, auditor ratification, advisory executive compensation votes, ordinary-share voting results and meeting procedures. Together, these filings provide formal records of Fabrinet’s manufacturing-services business disclosures, capital and shareholder structure, compensation oversight and public-company governance.
Darlene S. Knight, a director of Fabrinet (FN), reported a sale of company stock. The Form 4 shows she disposed of 479 ordinary shares in a transaction dated 09/05/2025 at a reported price of $366 per share, leaving her with 3,684 shares beneficially owned following the sale. The filing was submitted by an attorney-in-fact on her behalf.
Fabrinet (FN) director Thomas F. Kelly reported a sale of company stock. The Form 4 shows a transaction dated 09/05/2025 in which 480 ordinary shares were disposed of at a price of $0 reported (code G). After the reported sale, Mr. Kelly beneficially owned 20,989 shares. The filing was signed by Andrew Chew as attorney-in-fact on 09/08/2025.
Form 144 notice by an individual related to Fabrinet (FN). The filer intends to sell 479 ordinary shares on 09/05/2025 through Citigroup Global Markets, with an aggregate market value of $175,314. The shares were acquired on 01/02/2024 by restricted stock vesting from Fabrinet and payment is noted as services rendered. The filing lists 35,728,074 shares outstanding for the class and identifies the NYSE as the exchange. The filer previously sold 1,200 shares on 08/27/2025 for $402,150. The notice contains the standard certification that the seller is not aware of undisclosed material adverse information.
Fabrinet (FN) Form 4: Harpal Gill, who serves as President & COO and a director, reported a sale of 14,203 ordinary shares on 09/04/2025 at a weighted average price of $355.147 per share (range $355.00 to $355.81). After the transaction Mr. Gill beneficially owned 13,983 shares. The filing was signed by an attorney-in-fact on behalf of Mr. Gill.
The form discloses the exact number of shares sold, the weighted average sale price, and the remaining beneficial ownership. No derivative transactions or amendments are reported.
Fabrinet (FN) reporting person Edward T. Archer, EVP Sales & Marketing, disclosed insider sales on 09/04/2025. The Form 4 shows three separate dispositions of ordinary shares: 1,300 shares sold at a weighted average price of $353.676, 1,533 shares sold at a weighted average price of $354.88, and 500 shares sold at a weighted average price of $355.327. The report lists sequential beneficial ownership after each sale of 8,677 shares, 7,144 shares, and 6,644 shares respectively, indicating a total of 3,333 shares disposed on that date. The filing includes explanatory notes that the reported prices are weighted averages over small price ranges and states that full per-price details will be provided upon request.
Form 144 notice for Fabrinet (FN) reports the proposed sale of 14,203 ordinary shares, with an aggregate market value of $5,042,065.00, through Citigroup Global Markets on the NYSE. The shares originated from a restricted stock vesting attributable to Fabrinet on 09/04/2025 and payment is listed as services rendered. The filing also discloses that Harpal Gill sold 18,675 ordinary shares on 06/04/2025 for gross proceeds of $4,482,018.00. The notice includes the required representation that the seller is not aware of undisclosed material adverse information about the issuer.
Fabrinet (FN) Form 144 notice reports a proposed sale of 3,333 ordinary shares through Citigroup Global Markets, Inc. on 09/04/2025 with an aggregate market value of $1,181,148.54. The filing states these shares were recorded as acquired in a Vested Share Account on 09/04/2025 and the payment type is noted as compensation. The filer also disclosed a recent sale on 08/29/2025 of 3,200 shares for gross proceeds of $1,069,440.00. By signing, the person represents no undisclosed material adverse information about the issuer.
Fabrinet director Rollance E. Olson reported two open-market dispositions of ordinary shares, selling 8,700 shares and 300 shares on 09/02/2025 at weighted average prices of approximately $334.107 and $334.565 per share, respectively. Following those transactions the reported beneficial ownership decreased to 14,501 shares after the larger sale and to 14,201 shares after the second sale. The filing includes explanatory notes that the sale prices are weighted averages across narrow price ranges and that detailed per-price quantities are available on request.
Fabrinet executive Edward T. Archer, EVP Sales & Marketing, reported open-market sales of 3,200 Ordinary Shares on August 29, 2025, in two tranches of 2,325 shares at $334.984 and 875 shares at $335.536 per share. The reported sale prices are weighted averages over ranges of $334.20–$335.155 and $335.21–$336.086 per share. After these transactions he directly holds 9,977 shares.
Fabrinet (symbol FN) filed a Form 144 reporting a proposed sale of 9,000 ordinary shares through Citigroup Global Markets on the NYSE, with an aggregate market value of $3,009,240. The shares were acquired the same day, listed as restricted stock vesting from Fabrinet and paid as compensation. The filer reports no securities sold in the past three months and affirms they are not aware of any undisclosed material adverse information about the issuer. The notice identifies the sale as to be executed approximately on 09/02/2025.